The classical complement pathway typically requires antigen—antibody complexes (immune complexes) for activation (specific immune response), whereas the alternative pathway can be activated by C3 ...
A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results